Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 287 for Lung cancer

Edit search filters
  1. Radiotherapy To Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Tool For Improving The Shared Decision-making Process In Patients With Non-small Cell Lung Cancer

    Rochester, MN

  3. Neoadjuvant Dual Checkpoint Blockade With PD1 And LAG-3 Inhibition In Resectable Non-small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  4. Pulmonary Rehabilitation Before Lung Cancer Resection

    Jacksonville, FL, Rochester, MN

  5. Anesthesia And Non-small Cell Lung Cancer Recurrence

    Jacksonville, FL

  6. Chemotherapy Combined With Immunotherapy Vs Immunotherapy Alone For Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    Eau Claire, WI, Mankato, MN

  7. A Study To Assess Disease Activity And Adverse Events Of Intravenous (IV) Telisotuzumab Vedotin Compared To IV Docetaxel In Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Selpercatinib Following Definitive Locoregional Treatment In Participants With Non-small Cell Lung Cancer

    Rochester, MN

  9. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy In Previously Treated Advanced Or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations Or Other Genomic Alterations (MK-2870-004)

    Jacksonville, FL, Rochester, MN

  10. PKCι & MTOR Inhibition With Auranofin+Sirolimus For Squamous Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer